← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
GOLDMAN SACHS & CO. LLC
10% Owner | Other
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0000769993
Purchase history
- Companies traded
- 3
- Purchases · 12M
- 5
- Purchases · 24M
- 5
- Average purchase
- $4.8M
- Median purchase
- $3.4M
- Gross purchase value
- $24.0M
Companies: Attovia Therapeutics, Inc. | QVC Group, Inc. | Sweetgreen, Inc.
5 SEC accession(s) · 5 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-08-28 | Attovia Therapeutics, Inc. | ATTO | Other | $10.3M | Open filing |
| 2026-08-13 | Attovia Therapeutics, Inc. | ATTO | Other | $10.3M | Open filing |
| 2026-04-24 | QVC Group, Inc. | QVCGP | 10% Owner | $5.5K | Open filing |
| 2026-04-22 | QVC Group, Inc. | QVCGP | 10% Owner | $5.5K | Open filing |
| 2026-04-09 | Sweetgreen, Inc. | SG | 10% Owner | $3.4M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small Sample | 40.0% (2/5) | 100.0% (2/2) | +15.3% | +15.3% | +7.3% |
| 20D | 2Small Sample | 40.0% (2/5) | 50.0% (1/2) | +3.0% | +3.0% | -14.5% |
| 60D | 0No Data | 0.0% (0/3) | — | — | — | — |
| 120D | 0No Data | 0.0% (0/3) | — | — | — | — |
Research patterns
- First purchase in 12M
- 3/5
- Large purchase ≥ $100k
- 3/5
- Cluster buying · 15D
- 5/5
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.